B. 1. Tunkel, A. Glaser, C. Bloch, K. Sejvar, J. Marra et al., The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.47, issue.3, p.30327, 2008.
DOI : 10.1086/589747

F. Jmor, H. Emsley, M. Fischer, T. Solomon, P. Lewthwaite et al., The incidence of acute encephalitis syndrome in Western industrialised and tropical countries Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis, Virol J. Eur J Clin Microbiol Infect Dis. déc, vol.528, issue.12, p.14219, 2008.

E. Lancaster and J. Dalmau, Neuronal autoantigens???pathogenesis, associated disorders and antibody testing, Nature Reviews Neurology, vol.34, issue.7, p.38090, 2012.
DOI : 10.1038/nrneurol.2012.99

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718498

F. Graus, M. Titulaer, R. Balu, S. Benseler, C. Bien et al., A clinical approach to diagnosis of autoimmune encephalitis Insights into antibody-associated encephalitis-- Bickerstaff's 1950's papers revisited, Lancet Neurol. avr Bickerstaff ER, Cloake PCP. Mesencephalitis and Rhombencephalitis Br Med J. 14 juill J Neurol Sci. 15 nov, vol.152334, issue.6472312, pp.7781-7788, 1951.

S. Bigi, M. Hladio, M. Twilt, J. Dalmau, S. Benseler et al., The growing spectrum of antibody-associated inflammatory brain diseases in children Disponible sur: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399215/ 9 A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE Prevalence and burden of pediatric-onset systemic lupus erythematosus Understanding the epidemiology and progression of systemic lupus erythematosus, The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. 13. Levy DM, Kamphuis S. Systemic lupus erythematosus in children and adolescents, pp.20155384625768-12599608, 1999.

L. Hiraki, S. Benseler, P. Tyrrell, D. Hebert, E. Harvey et al., Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case?control study within LUMINA, a multiethnic US cohort (LUMINA LVII), J Pediatr. avr Lupus, vol.15217, issue.44, pp.5506-15314, 2008.

J. Hanly, M. Urowitz, L. Su, S. Bae, C. Gordon et al., childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus, Systemic lupus erythematosus (SLE), pp.456952935-456952953, 1998.

E. Zirkzee, T. Huizinga, E. Bollen, M. Van-buchem, H. A. Middelkoop et al., Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE) Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease, Lupus. PLoS ONE. Lupus. Neurology. 14 août Pego-Reigosa JM Rheumatology oct, vol.238155747, issue.2210, pp.318-55843, 2001.

S. Appenzeller, F. Cendes, and L. Costallat, Acute psychosis in systemic lupus erythematosus, Rheumatology International, vol.54, issue.56, pp.23743-23767, 2008.
DOI : 10.1007/s00296-007-0410-x

D. Marra, Lupus et troubles psychiatriquesO : du diagnostic étiologique au traitement
DOI : 10.1016/j.amp.2004.11.004

A. Médico-psychologiques,-revue-psychiatrique-brelinski, L. Cottencin, O. Guardia, D. Anguill, J. Queyrel et al., Ward MM, Studenski S. The time course of acute psychiatric episodes in systemic lupus erythematosus Catatonia and systemic lupus erythematosus: a clinical study of three cases):902. 27 Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia, al. Plasma exchange in patients with stuporous catatonia and systemic lupus erythematosus, pp.80612-255359, 1990.

M. Raffin, K. Deiva, X. Salle-collemiche, A. Lepine, and M. Spodenkiewicz, Catatonia and Autoimmune Conditions in Children and Adolescents: Should We Consider a Therapeutic Challenge? Medical and developmental risk factors of catatonia in children and adolescents: A prospective case control study, Psychother Psychosom. J Child Adolesc Psychopharmacol, vol.77, issue.30, pp.1956-1985, 2008.

J. Brandt, C. Johnson, M. Maldonado, S. Patel, and C. Ford, The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus, ):S55. 31. Sibbitt WL):153642. 32. Tomietto P, 2002.

G. Bertsias, J. Ioannidis, J. Boletis, S. Bombardieri, R. Cervera et al., General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus EULAR recommendations for the management of systemic lupus erythematosus Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics, Arthritis Rheum. 15 déc Ann Rheum Dis. févr, vol.5767, issue.82, pp.146172-33195205, 2007.

N. Ruth and A. German, Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies, J Rheumatol. mai, vol.30, issue.5, 2003.

E. Muscal, D. Bloom, J. Hunter, B. Myones, E. Kozora et al., Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution Cognitive dysfunction in systemic lupus erythematosus: past, present, and future Cognitive and emotional disturbances in systemic lupus erythematosus Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review, Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus. Arthritis Rheum. 15 oct-4):12631. 39. Denburg SD, pp.117482-3626879, 1987.

J. Hanly, . Diagnosis, . Management, J. Luyendijk, S. Steens et al., Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms, Nat Rev Rheumatol. juin Arthritis Rheum. mars J Neurol Neurosurg Psychiatr. mars, vol.106358, issue.633, pp.33847-4372232, 1995.

S. Appenzeller, F. Cendes, L. Costallat, A. González-duarte, G. García-ramos et al., Epileptic seizures in systemic lupus erythematosus Clinical description of intracranial hemorrhage associated with bleeding disorders, Neurology. 23 nov J Stroke Cerebrovasc Dis. août, vol.6317, issue.464, pp.1808122047-1808122094, 2004.

P. D. Neurolupus, A. Z. , C. D. , S. P. , M. F. et al., Case Study: Effectiveness of Plasma Exchange in an Adolescent With Systemic Lupus Erythematosus and Catatonia Journal of the American Academy of Child & Adolescent Psychiatry Cerebral systemic lupus erythematosus presenting with catatonia Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations, Description des outils diagnostiques et thérapeutiques devant une manifestation psychiatrique ou neurologique centrale au cours du lupus érythémateux systémique Psychiatric Symptoms, and Hypoventilation in Ovarian Teratoma, pp.50313-50361, 1985.

?. Anti, Receptor Encephalitis Associated with Ovarian Teratoma The Frequency of, ):2536. 55. Gable MS, Sheriff H, 2007.

N. Autoimmune, Aspartate Receptor Encephalitis Surpasses That of Individual Viral Etiologies in Young Individuals Enrolled in the California Encephalitis Project, Clin Infect Dis. 1 avr, vol.54, issue.7, pp.899904-56, 2012.

T. Armangue, M. Petit-pedrol, J. Dalmau, L. Mccracken, I. Gabilondo et al., Autoimmune encephalitis in children Treatment and prognostic factors for long-term outcome in patients with, J Child Neurol. nov, vol.27, issue.11, 2012.

A. Dalmau, J. Gleichman, A. Hughes, E. Rossi, J. Peng et al., NMDA) receptor encephalitis: a cohort study Anti-NMDAreceptor encephalitis: case series and analysis of the effects of antibodies, Lancet Neurol. févr Lancet Neurol. déc Dalmau J, vol.127, issue.212, pp.15765-5810918, 2008.

L. Mccracken and I. Cuellar, Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis, Lancet Neurol. janv, vol.10, issue.1, 2011.

R. Gordon, Clinical Features, Treatment, and Outcome of 500 Patients with Anti-NMDA Receptor Encephalitis (PL01.001), Neurology. 25 avr, vol.78, issue.1, 2012.

V. Desestret, F. Ducray, G. Picard, G. Cavillon, and V. Rogemond, Encephalitis in Children and Adolescents Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis, Aspartate Receptor (NMDAR), pp.11855663-63, 2009.

S. Bigi, M. Hladio, M. Twilt, J. Dalmau, and S. Benseler, The growing spectrum of antibody-associated inflammatory brain diseases in children Disponible sur, Neurol Neuroimmunol Neuroinflamm, vol.2, issue.64, 2015.

G. Maccaferri, A. Rossetti, J. Dalmau, A. Berney, Y. Anti-hacohen et al., Aspartate Receptor Encephalitis: A New Challenging Entity for Consultation-Liaison Psychiatrist Disponible sur: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959779/ 65 N-methyl-daspartate (NMDA) receptor antibodies encephalitis mimicking an autistic regression Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents, Brain Disord Ther [Internet] Dev Med Child Neurol. 3 juin Curr Opin Pediatr. déc, vol.522, issue.666, pp.73944-67, 2010.

S. Irani, A. Vincent, . Nmda-receptor-antibody-encephalitis-68, M. Zandi, S. Irani et al., Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma Diagnosis and significance of antibody titers in anti-NMDA receptor encephalitis, a retrospective studyAnti-NMDA-receptor encephalitis. An interdisciplinary clinical picture] Prolonged Follow-up and CSF Antibody Titers in a Patient With Anti-NMDA Receptor Encephalitis, Curr Neurol Neurosci Rep Neurology. 8 déc Lancet Neurol. févr Nervenarzt. avr Neurology. 15 févr, vol.117313817675, issue.400 2, pp.20394016777396-646, 2009.

M. Seki, S. Suzuki, T. Iizuka, T. Shimizu, Y. Nihei et al., Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis Serial and prolonged EEG monitoring in anti-N-Methyl-d-Aspartate receptor encephalitis, J Neurol Neurosurg Psychiatry. mars Clin Neurophysiol. août, vol.79125, issue.38, pp.3246-7415414, 2008.

A. Encephalitis-the-padua-experience-bayreuther, C. Bourg, V. Dellamonica, J. Borg, M. Bernardin et al., Complex partial status epilepticus revealing anti-NMDA receptor encephalitis Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis Early and persistent 'extreme delta brush' in a patient with anti-NMDA receptor encephalitis, J Child Neurol. 5 janv Epileptic Disord. sept Neurology. 11 sept Epilepsy & Behavior Case Reports, vol.11792, issue.311, pp.2615-776770, 2009.

A. Simonnet, H. Eisermann, M. Leunen, D. Dulac, O. Nabbout et al., Clinical analysis and novel findings in a series of 20 patients Early electro-clinical features may contribute to diagnosis of the anti-NMDA receptor encephalitis in children, J Pediatr. avr Clin Neurophysiol. déc, vol.162124, issue.412, pp.8506235461-81, 2013.

F. Sakai and H. Mochizuki, Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyUpdate on anti-NMDA receptor encephalitis], Lancet Neurol. févr Brain Nerve. avr, vol.1262, issue.24, pp.3318-84, 2010.

J. Heine, H. Prüss, T. Bartsch, C. Ploner, F. Paul et al., Imaging of autoimmune encephalitis ? Relevance for clinical practice and hippocampal function. Neuroscience Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond, Nat Rev Drug Discov. févr, vol.3095, issue.852, pp.688316070-86, 2006.

T. Iizuka, F. Sakai, T. Ide, T. Monzen, S. Yoshii et al., Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal, Neurology, vol.70, issue.7, pp.41128-8850411, 2008.
DOI : 10.1212/01.wnl.0000278388.90370.c3

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586938

S. Pillai, D. Gill, R. Webster, R. Howman-giles, R. Dale et al., Cortical Hypometabolism Demonstrated by PET in Relapsing NMDA Receptor Encephalitis Pediatric Neurology. 1 sept Anti?NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders, Curr Treat Options Neurol. 5 févr, vol.4313, issue.33, pp.21720-9132432, 2010.
DOI : 10.1016/j.pediatrneurol.2010.04.019

?. Anti, E. Hughes, X. Peng, A. Gleichman, M. Lai et al., Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction, Ann Neurol. janv J Neurosci. 28 avr Orphanet J Rare Dis, vol.61305, issue.117, pp.2536-93586675, 2007.

M. Lamarque, D. Psimaras, F. Ducray, I. Pelieu, R. Sonneville et al., Encéphalites auto-immunes à anticorps antirécepteurs-NMDA, une cause fréquente d'encéphalite en réanimation. Réanimation. 28 juin, 2011.
DOI : 10.1007/s13546-011-0275-6

M. Leboyer, J. Oliveira, R. Tamouza, and L. Groc, Is it time for immunopsychiatry in psychotic disorders? Psychopharmacology (Berl), pp.165160-98, 2016.

L. Guen, E. Guen, R. Doukhan, N. Hamdani, R. Tamouza et al., Anticorps anti-NR1 dans l'encéphalite anti-récepteur N-méthyl-D-aspartate et la schizophrénie. médecine/sciences Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges, Ther Clin Risk Manag. 1 juill, p.51725, 2014.

H. Verhelst, P. Verloo, K. Dhondt, B. Paepe, B. Menten et al., Anti-NMDAreceptor encephalitis in a 3 year old patient with chromosome 6p21.32 microdeletion including the HLA cluster, European Journal of Paediatric Neurology. 1 mars, vol.15, issue.2, p.1636, 2011.

S. Ramanathan, S. Mohammad, F. Brilot, and R. Dale, Autoimmune encephalitis: Recent updates and emerging challenges, Journal of Clinical Neuroscience, vol.21, issue.5, p.72230, 2014.
DOI : 10.1016/j.jocn.2013.07.017

L. Sansing, E. Tüzün, M. Ko, J. Baccon, D. Lynch et al., A patient with encephalitis associated with NMDA receptor antibodies, Nature Clinical Practice Neurology, vol.26, issue.5, p.2916, 2007.
DOI : 10.1038/ncpneuro0493

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936221

H. Prüss, C. Finke, M. Höltje, J. Hofmann, C. Klingbeil et al., N-methyl-Daspartate receptor antibodies in herpes simplex encephalitis, Ann Neurol. déc, vol.72, issue.6, p.90211, 2012.

M. Kayser and J. Dalmau, Anti-NMDA Receptor Encephalitis in Psychiatry, Current Psychiatry Reviews, vol.7, issue.3, p.18993, 2011.
DOI : 10.2174/157340011797183184

M. Nosadini, S. Mohammad, S. Ramanathan, F. Brilot, and R. Dale, Immune therapy in autoimmune encephalitis: a systematic review, Expert Review of Neurotherapeutics, vol.15, issue.12, p.1391419, 2015.
DOI : 10.1586/14737175.2015.1115720

T. Armangue, M. Petit-pedrol, and J. Dalmau, Autoimmune Encephalitis in Children, Journal of Child Neurology, vol.158, issue.3, p.14609, 2012.
DOI : 10.1212/WNL.0b013e3182143552

E. Lancaster, The Diagnosis and Treatment of Autoimmune Encephalitis, Journal of Clinical Neurology, vol.12, issue.1, p.113, 2016.
DOI : 10.3988/jcn.2016.12.1.1

M. Nosadini, S. Mohammad, S. Ramanathan, F. Brilot, and R. Dale, Immune therapy in autoimmune encephalitis: a systematic review, Expert Review of Neurotherapeutics, vol.15, issue.12, p.1391419, 2015.
DOI : 10.1586/14737175.2015.1115720

A. Suppiej, M. Nosadini, L. Zuliani, M. Pelizza, I. Toldo et al., Plasma exchange in pediatric anti-NMDAR encephalitis: A systematic review, Brain and Development, vol.38, issue.7, p.61322, 2016.
DOI : 10.1016/j.braindev.2016.01.009

A. Desena, D. Noland, K. Matevosyan, K. King, L. Phillips et al., Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-nmethyl-d-aspartate receptor antibody encephalitis: A retrospective review, J Clin Apheresis. 1 août, vol.30, issue.4, p.2126, 2015.

R. Dale, F. Brilot, L. Duffy, M. Twilt, A. Waldman et al., Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease, Neurology, vol.83, issue.2, p.14250, 2014.
DOI : 10.1212/WNL.0000000000000570

S. Tatencloux, P. Chretien, V. Rogemond, J. Honnorat, M. Tardieu et al., -aspartate receptor encephalitis in children, Developmental Medicine & Child Neurology, vol.13, issue.1, p.959, 2015.
DOI : 10.1111/dmcn.12545

H. Alexopoulos, M. Kosmidis, J. Dalmau, and M. Dalakas, Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies, Journal of Neurology, vol.70, issue.8, p.156870, 2011.
DOI : 10.1007/s00415-011-5982-4

J. Linnoila, M. Rosenfeld, and J. Dalmau, Neuronal Surface Antibody-Mediated Autoimmune Encephalitis, Seminars in Neurology, vol.34, issue.04, p.45866, 2014.
DOI : 10.1055/s-0034-1390394

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838036

E. Lancaster, E. Martinez-hernandez, and J. Dalmau, Encephalitis and antibodies to synaptic and neuronal cell surface proteins, Neurology, vol.77, issue.2, p.17989, 2011.
DOI : 10.1212/WNL.0b013e318224afde

F. Ferracci, G. Bertiato, and G. Moretto, Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations, Journal of the Neurological Sciences, vol.217, issue.2, p.1658, 2004.
DOI : 10.1016/j.jns.2003.09.007

F. Ferracci and A. Carnevale, The neurological disorder associated with thyroid autoimmunity, Journal of Neurology, vol.59, issue.8, p.97584, 2006.
DOI : 10.1007/s00415-006-0170-7

G. Montagna, M. Imperiali, P. Agazzi, D. Aurizio, F. Tozzoli et al., Hashimoto's encephalopathy: A rare proteiform disorder, Autoimmunity Reviews, vol.15, issue.5, p.46676, 2016.
DOI : 10.1016/j.autrev.2016.01.014

G. Marshall and J. Doyle, Long-Term Treatment of Hashimoto???s Encephalopathy, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.18, issue.1, p.1420, 2006.
DOI : 10.1176/jnp.18.1.14

A. Antonelli, S. Ferrari, A. Corrado, D. Domenicantonio, A. Fallahi et al., Autoimmune thyroid disorders, Autoimmunity Reviews, vol.14, issue.2, p.17480, 2015.
DOI : 10.1016/j.autrev.2014.10.016

M. Rallison, B. Dobyns, M. Keating, F. Rall, J. et al., Occurrence and natural history of chronic lymphocytic thyroiditis in childhood, The Journal of Pediatrics, vol.86, issue.5, p.67582, 1975.
DOI : 10.1016/S0022-3476(75)80350-7

I. Kothbauer-margreiter, M. Sturzenegger, J. Komor, R. Baumgartner, and C. Hess, Encephalopathy associated with Hashimoto thyroiditis: Diagnosis and treatment, Journal of Neurology, vol.37, issue.8, p.58593, 1996.
DOI : 10.1007/BF00900946

C. Carlone, L. Todini, I. Marini, M. Majorana, S. Casciato et al., Acute psychiatric presentation of steroid-responsive encephalopathy: the under recognized side of autoimmune thyroiditis, Riv Psichiatr. avr, vol.48, issue.2, p.16973, 2013.

R. Wilcox, T. To, A. Koukourou, and J. Frasca, Hashimoto???s encephalopathy masquerading as acute psychosis, Journal of Clinical Neuroscience, vol.15, issue.11, p.13014, 2008.
DOI : 10.1016/j.jocn.2006.10.019

F. Mahmud, A. Lteif, D. Renaud, A. Reed, and C. Brands, Steroid-Responsive Encephalopathy Associated With Hashimoto's Thyroiditis in an Adolescent With Chronic Hallucinations and Depression: Case Report and Review, PEDIATRICS, vol.112, issue.3, p.68690, 2003.
DOI : 10.1542/peds.112.3.686

C. Nunnemann and T. Kratz, Hashimoto encephalopathy--a difficult differential diagnosis. A case report of reversible dementia and psychosis], Fortschr Neurol Psychiatr. oct, vol.76, issue.10, p.6105, 2008.

E. Vasconcellos, J. Piña-garza, T. Fakhoury, and G. Fenichel, Pediatric manifestations of Hashimoto???s encephalopathy, Pediatric Neurology, vol.20, issue.5, p.3948, 1999.
DOI : 10.1016/S0887-8994(99)00006-5

J. Alink and T. De-vries, Unexplained seizures, confusion or hallucinations: think Hashimoto encephalopathy, Acta Paediatrica, vol.143, issue.4, p.4513, 2008.
DOI : 10.1212/01.WNL.0000150733.84323.8F

N. Gayatri and W. Whitehouse, Pilot survey of Hashimoto's encephalopathy in children

J. Chong, L. Rowland, and R. Utiger, Hashimoto Encephalopathy, Archives of Neurology, vol.60, issue.2, p.16471, 2003.
DOI : 10.1001/archneur.60.2.164

C. Zois, I. Stavrou, C. Kalogera, E. Svarna, I. Dimoliatis et al., High Prevalence of Autoimmune Thyroiditis in Schoolchildren After Elimination of Iodine Deficiency in Northwestern Greece, Thyroid, vol.13, issue.5, p.4859, 2003.
DOI : 10.1089/105072503322021151

D. Vander, C. Hallevy, I. Alsaed, S. Valdman, G. Ifergane et al., 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy, J Neurol. oct, vol.251, issue.10, p.12734, 2004.

P. Shaw, T. Walls, P. Newman, P. Cleland, and N. Cartlidge, Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers--report of 5 cases, Neurology. févr, vol.41, issue.2, p.22833, 1991.

D. Nandi-munshi and C. Taplin, Thyroid-Related Neurological Disorders and Complications in??Children, Pediatric Neurology, vol.52, issue.4, p.37382, 2015.
DOI : 10.1016/j.pediatrneurol.2014.12.005

B. Schäuble, P. Castillo, B. Boeve, and B. Westmoreland, EEG findings in steroidresponsive encephalopathy associated with autoimmune thyroiditis, Clinical Neurophysiology. janv, vol.114, issue.1, p.327, 2003.

Y. Song, D. Seo, and G. Chang, MR Findings in Hashimoto Encephalopathy, AJNR Am J Neuroradiol. 1 mai, vol.25, issue.5, p.8078, 2004.

D. Mccabe, T. Burke, S. Connolly, and M. Hutchinson, Amnesic syndrome with bilateral mesial temporal lobe involvement in Hashimoto's encephalopathy, Neurology, vol.54, issue.3, p.7379, 2000.
DOI : 10.1212/WNL.54.3.737

P. Zimmermann and E. Stranzinger, Steroid-responsive encephalopathy associated with Hashimoto thyroiditis, Pediatric Radiology, vol.42, issue.7, p.8913, 2011.
DOI : 10.1007/s00247-011-2309-7

N. Bohnen, K. Parnell, and C. Harper, Reversible MRI findings in a patient with Hashimoto's encephalopathy, Neurology, vol.49, issue.1, p.2467, 1997.
DOI : 10.1212/WNL.49.1.246

M. Rössler and J. Klotz, Celebral vasculitis and autoimmune thyreoiditis], Fortschr Neurol Psychiatr. mars, vol.76, issue.3, p.1669, 2008.

E. Pari, F. Rinaldi, E. Premi, M. Codella, R. Rao et al., A follow-up 18 F-FDG brain PET study in a case of Hashimoto's encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis, J Neurol. avr, vol.261, issue.4, p.6637, 2014.

M. Piga, A. Serra, L. Deiana, G. Loi, L. Satta et al., Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis, European Journal of Nuclear Medicine and Molecular Imaging, vol.9, issue.12, p.163944, 2004.
DOI : 10.1007/s00259-004-1625-7

G. Zettinig, S. Asenbaum, B. Fueger, A. Hofmann, M. Diemling et al., Increased prevalence of sublinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto's encephalitis?, Clinical Endocrinology, vol.12, issue.5, p.63743, 2003.
DOI : 10.1046/j.1365-2249.2003.02089.x

N. Watemberg, D. Greenstein, and A. Levine, Encephalopathy associated with Hashimoto thyroiditis: pediatric perspective, J Child Neurol. janv, vol.21, issue.1, p.15, 2006.
DOI : 10.1177/08830738060210010201

V. Fatourechi, Hashimoto's encephalopathy: myth or reality? An endocrinologist's perspective, Best Practice & Research Clinical Endocrinology & Metabolism, vol.19, issue.1, p.5366, 2005.
DOI : 10.1016/j.beem.2004.11.006

F. Ghawche, R. Bordet, and A. Destée, [Hashimoto's encephalopathy: toxic or autoimmune mechanism?], Rev Neurol, vol.148, issue.5, p.3713, 1992.

K. Nolte, A. Unbehaun, H. Sieker, T. Kloss, and W. Paulus, Hashimoto encephalopathy: a brainstem vasculitis? Neurology, févr, vol.54, issue.3, p.76970, 2000.
DOI : 10.1212/wnl.54.3.769

P. Duffey, Y. S. Reid, I. Bridges, and L. , Hashimoto's encephalopathy: Postmortem findings after fatal status epilepticus, Neurology, vol.61, issue.8, p.11246, 2003.
DOI : 10.1212/01.WNL.0000090462.62087.A1

A. Fujii, M. Yoneda, T. Ito, O. Yamamura, S. Satomi et al., Autoantibodies against the amino terminal of ??-enolase are a useful diagnostic marker of Hashimoto's encephalopathy, Journal of Neuroimmunology, vol.162, issue.1-2, p.1306, 2005.
DOI : 10.1016/j.jneuroim.2005.02.004

A. Cantón, O. De-fàbregas, M. Tintoré, J. Mesa, A. Codina et al., Encephalopathy associated to autoimmune thyroid disease: a more appropriate term for an underestimated condition?, Journal of the Neurological Sciences, vol.176, issue.1, p.659, 2000.
DOI : 10.1016/S0022-510X(00)00302-6

R. Caselli, B. Boeve, B. Scheithauer, O. Duffy, J. Hunder et al., Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): A reversible form of encephalopathy, Neurology, vol.53, issue.7, p.157981, 1999.
DOI : 10.1212/WNL.53.7.1579

S. Bannier, F. Taithe, C. Solmon, P. Thieblot, and P. Clavelou, Encéphalopathie corticosensible associée à une thyroidite auto-immuneO : données actuelles, Annales d'Endocrinologie. juin, vol.68, pp.2-316772, 2007.
DOI : 10.1016/j.ando.2007.01.022

Ö. Bektas, A. Y?lmaz, T. Kendirli, Z. S?klar, and G. Deda, Hashimoto Encephalopathy Causing Drug-Resistant Status Epilepticus Treated With Plasmapheresis, Pediatric Neurology, vol.46, issue.2, p.1325, 2012.
DOI : 10.1016/j.pediatrneurol.2011.11.009

I. Olmez, H. Moses, S. Sriram, H. Kirshner, A. Lagrange et al., Diagnostic and therapeutic aspects of Hashimoto's encephalopathy, Journal of the Neurological Sciences, vol.331, issue.1-2, p.6771, 2013.
DOI : 10.1016/j.jns.2013.05.009

M. Taylor and M. Fink, Catatonia in Psychiatric Classification: A Home of Its Own, American Journal of Psychiatry, vol.160, issue.7, p.123341, 2003.
DOI : 10.1176/appi.ajp.160.7.1233

M. Raffin, L. Zugaj-bensaou, N. Bodeau, V. Milhiet, C. Laurent et al., Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia, European Child & Adolescent Psychiatry, vol.5, issue.1, p.4419, 2015.
DOI : 10.1007/s00787-014-0595-y

R. Tandon, S. Heckers, J. Bustillo, D. Barch, W. Gaebel et al., Catatonia in DSM-5, Schizophrenia Research, vol.150, issue.1, p.2630, 2013.
DOI : 10.1016/j.schres.2013.04.034

A. Francis, M. Fink, F. Appiani, A. Bertelsen, T. Bolwig et al., Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, The Journal of ECT, vol.26, issue.4, p.2467, 2010.
DOI : 10.1097/YCT.0b013e3181fe28bd

O. Cottencin, P. Thomas, G. Vaiva, C. Rascle, and M. Goudemand, A Case of Agitated Catatonia, Pharmacopsychiatry, vol.32, issue.01, p.3840, 1999.
DOI : 10.1055/s-2007-979186

URL : https://hal.archives-ouvertes.fr/hal-00336921

J. Morrison, Catatonia, Archives of General Psychiatry, vol.28, issue.1, p.3941, 1973.
DOI : 10.1001/archpsyc.1973.01750310023005

D. Dhossche, L. Stoppelbein, and U. Rout, Etiopathogenesis of Catatonia, The Journal of ECT, vol.26, issue.4, p.2538, 2010.
DOI : 10.1097/YCT.0b013e3181fbf96d

M. Belaizi, A. Yahia, J. Mehssani, B. Idrissi, M. Bichra et al., Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics], Encephale. juin, vol.39, issue.3, p.22431, 2013.

L. Patry, E. Guillem, F. Pontonnier, and M. Ferreri, Catatonia de novo, report on a case: immediate vital prognosis and psychiatric prognosis in longer term], Encephale. févr, vol.29, issue.1, p.729, 2003.

M. Fink, Toxic serotonin syndrome or neuroleptic malignant syndrome? Pharmacopsychiatry, juill, vol.29, issue.4, p.15961, 1996.
DOI : 10.1055/s-2007-979564

S. Mann, S. Caroff, H. Bleier, W. Welz, M. Kling et al., Lethal catatonia, Am J Psychiatry. nov, vol.143, issue.11, p.137481, 1986.

K. Takaoka and T. Takata, Catatonia in childhood and adolescence, Psychiatry and Clinical Neurosciences, vol.14, issue.2, p.12937, 2003.
DOI : 10.1007/s007870050109

G. Northoff, A. Koch, J. Wenke, J. Eckert, H. Böker et al., Catatonia as a psychomotor syndrome: A rating scale and extrapyramidal motor symptoms, Movement Disorders, vol.92, issue.3, p.40416, 1999.
DOI : 10.1002/1531-8257(199905)14:3<404::AID-MDS1004>3.0.CO;2-5

P. Rosebush, A. Hildebrand, B. Furlong, and M. Mazurek, Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam, J Clin Psychiatry. sept, vol.51, issue.9, p.35762, 1990.

R. Abrams, M. Taylor, C. Stolurow, and K. , Catatonia and mania: patterns of cerebral dysfunction, Biol Psychiatry. févr, vol.14, issue.1, p.1117, 1979.

P. Rosebush and M. Mazurek, Catatonia: Re-awakening to a forgotten disorder, Movement Disorders, vol.52, issue.3, p.3957, 1999.
DOI : 10.1002/1531-8257(199905)14:3<395::AID-MDS1002>3.0.CO;2-L

D. Cohen, J. Nicolas, M. Flament, D. Périsse, P. Dubos et al., Clinical relevance of chronic catatonic schizophrenia in children and adolescents: Evidence from a prospective naturalistic study, Schizophrenia Research, vol.76, issue.2-3, pp.2-33018, 2005.
DOI : 10.1016/j.schres.2005.01.014

D. Cohen, Towards A Valid Nosography and Psychopathology of Catatonia in Children and Adolescents Academic Press Disponible sur, Dirk Marcel Dhossche LW Masataka Ohta and Klaus2 Jürgen Neumärker, éditeur, 2006.

G. Bush, M. Fink, G. Petrides, F. Dowling, and A. Francis, Catatonia. I. Rating scale and standardized examination, Acta Psychiatrica Scandinavica, vol.93, issue.2, p.12936, 1996.
DOI : 10.1111/j.1600-0447.1996.tb09814.x

X. Benarous, A. Consoli, M. Raffin, N. Bodeau, M. Giannitelli et al., Validation of the Pediatric Catatonia Rating Scale (PCRS), Schizophrenia Research, vol.176, issue.2-3, 2016.
DOI : 10.1016/j.schres.2016.06.020

G. Northoff, W. Krill, J. Wenke, B. Gille, M. Russ et al., Major Differences in Subjective Experience of Akinetic States in Catatonic and Parkinsonian Patients, Cognitive Neuropsychiatry, vol.51, issue.3, p.16178, 1998.
DOI : 10.1136/jnnp.60.3.326

P. Rosebush and M. Mazurek, Catatonia and Its Treatment, Schizophrenia Bulletin, vol.36, issue.2, p.23942, 2010.
DOI : 10.1093/schbul/sbp141

D. Dhossche, S. Shettar, T. Kumar, and L. Burt, Electroconvulsive Therapy for Malignant Catatonia in Adolescence, Southern Medical Journal, vol.102, issue.11, p.11702, 2009.
DOI : 10.1097/SMJ.0b013e3181b9e39c

G. Bush, M. Fink, G. Petrides, F. Dowling, and A. Francis, Catatonia. II. Treatment with lorazepam and electroconvulsive therapy, Acta Psychiatrica Scandinavica, vol.145, issue.3, p.13743, 1996.
DOI : 10.1016/0163-8343(91)90024-Q

S. Pichini, E. Papaseit, J. X. Vall, O. Farré, M. Garcia-algar et al., Pharmacokinetics and Therapeutic Drug Monitoring of Psychotropic Drugs in Pediatrics, Therapeutic Drug Monitoring, vol.31, issue.3, p.283318, 2009.
DOI : 10.1097/FTD.0b013e31819f3328

D. Cohen, M. Flament, O. Taieb, C. Thompson, and M. Basquin, Electroconvulsive therapy in adolescence, European Child & Adolescent Psychiatry, vol.9, issue.1, p.16, 2000.
DOI : 10.1007/s007870050109

F. Van-den-eede, J. Van-hecke, A. Van-dalfsen, B. Van-den-bossche, P. Cosyns et al., The use of atypical antipsychotics in the treatment of catatonia, Eur Psychiatry. août, vol.20, pp.5-64229, 2005.

A. Consoli, K. Ronen, I. An-gourfinkel, M. Barbeau, D. Marra et al., Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: case report. Child Adolesc Psychiatry Ment Health, p.15, 2011.

A. Consoli, M. Raffin, C. Laurent, N. Bodeau, D. Campion et al., Medical and developmental risk factors of catatonia in children and adolescents: A prospective case? control study, Schizophrenia Research. mai, vol.137, pp.1-31518, 2012.

B. Lahutte, F. Cornic, O. Bonnot, A. Consoli, I. An-gourfinkel et al., Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.32, issue.6, p.13938, 2008.
DOI : 10.1016/j.pnpbp.2008.02.015

O. Bonnot and N. Dumas, Schizophrenic disorders in adolescence], Rev Prat. avr, vol.64, issue.4, p.499504, 2014.

T. Mon, L. 'ecuyer, S. Farber, N. White, A. Baszis et al., The use of electroconvulsive therapy in a patient with juvenile systemic lupus erythematosus and catatonia, Lupus, vol.64, issue.14, p.157581, 2012.
DOI : 10.1002/art.1780251101

C. Finke, U. Kopp, H. Prüss, J. Dalmau, K. Wandinger et al., Cognitive deficits following anti-NMDA receptor encephalitis, Journal of Neurology, Neurosurgery & Psychiatry, vol.83, issue.2, p.1958, 2012.
DOI : 10.1136/jnnp-2011-300411

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718487

. Neurolupus, Description et démarche diagnostique et thérapeutique dans les manifestations neurologiques centrales et psychiatriques au cours du lupus érythémateux systémique, La Revue de Médecine Interne. sept, vol.33, issue.9, p.491502, 2012.

Y. Hacohen, S. Wright, P. Waters, S. Agrawal, L. Carr et al., Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens, Journal of Neurology, Neurosurgery & Psychiatry, vol.135, issue.7, p.74855, 2013.
DOI : 10.1136/jnnp-2012-303807

S. Byrne, C. Walsh, Y. Hacohen, E. Muscal, J. Jankovic et al., Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome Disponible sur, Neurol Neuroimmunol Neuroinflamm, vol.2, issue.4, 2016.

B. Lahutte, F. Cornic, O. Bonnot, A. Consoli, I. An-gourfinkel et al., Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.32, issue.6, p.13938, 2008.
DOI : 10.1016/j.pnpbp.2008.02.015

J. Honnorat, A. Didelot, E. Karantoni, D. Ville, F. Ducray et al., Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer, Neurology, vol.80, issue.24, p.222632, 2013.
DOI : 10.1212/WNL.0b013e318296e9c3

A. Zekeridou, E. Karantoni, A. Viaccoz, F. Ducray, C. Gitiaux et al., Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitis, Journal of Neurology, vol.51, issue.1, p.185966, 2015.
DOI : 10.1007/s00415-015-7781-9

L. Zuliani, F. Graus, B. Giometto, C. Bien, and A. Vincent, Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition, Journal of Neurology, Neurosurgery & Psychiatry, vol.83, issue.6, p.63845, 2012.
DOI : 10.1136/jnnp-2011-301237

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348613

A. Houtrow, M. Bhandal, N. Pratini, L. Davidson, and J. Neufeld, The Rehabilitation of Children with Anti-NMDA-Receptor Encephalitis: A Case Series, Am J Phys Med Rehabil. mai, vol.91, issue.5, p.43541, 2012.